Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application.

Biodegradable, biocompatible, renewable and non-toxic polyhydroxyalkanoates (PHAs) based nanoparticles are the novel nanotherapeutic tool which are used for the encapsulation of antineoplastic drugs for cancer therapy. In this study, poly-3-hydroxybutyrate-co-5 mol% 3-hydroxyvalerate (PHBV-S), poly-3-hydroxybutyrate-co-11 mol% 3-hydroxyvalerate (PHBV-11) and poly-3-hydroxybutyrate-co-15 mol% 3-hydroxyvalerate (PHBV-15) were used as a nanocarrier for encapsulation of Ellipticine (EPT). EPT is a model anticancer drug. Physicochemical characteristics such as particle size, its morphology and zeta potential of blank and EPT loaded PHBV-S, PHBV-11 and PHBV-15 nanoparticles were studied. In vitro cytotoxicity tests confirmed that the blank PHBV-S, PHBV-11 and PHBV-15 nanoparticles were demonstrating significant biocompatibility without affecting the survival of cancer cell line A549. The loading efficiency of EPT in PHBV nanoparticles was observed in the range of 39.32 to 45.65%. The % inhibition of cancer cell line A549 ranged from 64.28 to 67.77% in comparison to EPT alone in which % inhibition found to be ≤45.11%. The IC50 value for each of three different formulations of EPT loaded PHBV nanoparticles ranged from 1.00 to 1.31 μg/mL. The order of % inhibition of cancer cell line A549 for drug loaded nanoparticles was EPT-PHBV-15>EPT-PHBV-S>EPT-PHBV-11. This system had demonstrated a great potential to increase the cytotoxic effect of EPT by increasing its bioavailability.

[1]  S. Narine,et al.  Biotechnological approaches for the production of polyhydroxyalkanoates in microorganisms and plants - a review. , 2007, Biotechnology advances.

[2]  S. Guterres,et al.  Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly(ε-caprolactone) blends to control the release of a drug model , 2007, Journal of microencapsulation.

[3]  N. Özer,et al.  In vivo half life of nanoencapsulated L-asparaginase , 2002, Journal of materials science. Materials in medicine.

[4]  Hatem Fessi,et al.  Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .

[5]  M. Gleeson.  Generation of a set of simple, interpretable ADMET rules of thumb. , 2008, Journal of medicinal chemistry.

[6]  B Ruozi,et al.  PLA/PLGA nanoparticles for sustained release of docetaxel. , 2006, International journal of pharmaceutics.

[7]  R. Zhuo,et al.  Study on drug release behaviors of poly-alpha,beta-[n-(2-hydroxyethyl)-L-aspartamide]-g-poly(epsilon-caprolactone) nano- and microparticles. , 2006, Biomacromolecules.

[8]  A. Boccaccini,et al.  Polyhydroxyalkanoate (PHA) biosynthesis from structurally unrelated carbon sources by a newly characterized Bacillus spp. , 2007, Journal of biotechnology.

[9]  M. Fujita,et al.  Adsorption and hydrolysis reactions of poly(hydroxybutyric acid) depolymerases secreted from Ralstonia pickettii T1 and Penicillium funiculosum onto poly[(R)-3-hydroxybutyric acid]. , 2007, Biomacromolecules.

[10]  Emilio Hirsch,et al.  Sustained release of PI3K inhibitor from PHA nanoparticles and in vitro growth inhibition of cancer cell lines , 2011, Applied Microbiology and Biotechnology.

[11]  Hatem Fessi,et al.  Preparation and Characterization of Nanocapsules from Preformed Polymers by a New Process Based on Emulsification-Diffusion Technique , 1998, Pharmaceutical Research.

[12]  A. Llombart‐Bosch,et al.  New Trends in Cancer for the 21st Century , 2003, Advances in Experimental Medicine and Biology.

[13]  Min Wu,et al.  Release of hydrophobic anticancer drug from a newly designed self-assembling peptide. , 2011, Molecular bioSystems.

[14]  Yali Zhang,et al.  Preparation and in vitro drug‐release behavior of 5‐fluorouracil‐loaded poly(hydroxybutyrate‐co‐hydroxyhexanoate) nanoparticles and microparticles , 2010 .

[15]  S. Provencher.  A constrained regularization method for inverting data represented by linear algebraic or integral equations , 1982 .

[16]  M. Sakata,et al.  Chromatographic removal of endotoxin from protein solutions by polymer particles. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  P. Low,et al.  Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[18]  A. Steinbüchel,et al.  Poly(3-hydroxybutyrate) granule-associated proteins: impacts on poly(3-hydroxybutyrate) synthesis and degradation. , 2005, Biomacromolecules.

[19]  I. Noda,et al.  Microbial degradation and physico-chemical alteration of polyhydroxyalkanoates by a thermophilic Streptomyces sp. , 2009, Biologia.

[20]  Y. Inoue,et al.  Study of enzymatic degradation of microbial copolyesters consisting of 3-hydroxybutyrate and medium-chain-length 3-hydroxyalkanoates , 2007 .

[21]  H. Fessi,et al.  Physicochemical Parameters Associated with Nanoparticle Formation in the Salting-Out, Emulsification-Diffusion, and Nanoprecipitation Methods , 2004, Pharmaceutical Research.

[22]  C. Williams,et al.  Bacterial synthesis of biodegradable polyhydroxyalkanoates , 2007, Journal of applied microbiology.

[23]  S. Guterres,et al.  Protective properties of melatonin-loaded nanoparticles against lipid peroxidation. , 2005, International journal of pharmaceutics.

[24]  Xun Sun,et al.  Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo , 2006, Journal of materials science. Materials in medicine.

[25]  Sai T Reddy,et al.  In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[26]  A. Pich,et al.  Preparation of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) particles in O/W emulsion , 2006 .

[27]  Guo-qiang Chen,et al.  Application of Polyhydroxyalkanoates Nanoparticles as Intracellular Sustained Drug-Release Vectors , 2010, Journal of biomaterials science. Polymer edition.

[28]  Mohsin Shah,et al.  Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: preparation, characterization and in vitro evaluation. , 2010, International journal of pharmaceutics.

[29]  Baki Hazer,et al.  Amphiphilic Poly ( 3-hydroxy alkanoate ) s : Potential Candidates for Medical Applications , 2010 .

[30]  E. Allémann,et al.  Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[31]  A. V. Eschenbach,et al.  A vision for the National Cancer Program in the United States , 2004, Nature Reviews Cancer.

[32]  S. Guterres,et al.  Controlling the size of poly(hydroxybutyrate-co-hydroxyvalerate) nanoparticles prepared by emulsification-diffusion technique using ethanol as surface agent , 2008 .

[33]  I. Shim,et al.  Prolonged analgesic effect of PLGA-encapsulated bee venom on formalin-induced pain in rats. , 2009, International journal of pharmaceutics.

[34]  K. Fang,et al.  Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells. , 2009, Lung cancer.

[35]  Robert Langer,et al.  Nanotechnology in drug delivery and tissue engineering: from discovery to applications. , 2010, Nano letters.

[36]  C. Chien,et al.  Isolation of polyhydroxyalkanoates‐producing bacteria using a combination of phenotypic and genotypic approach , 2007, Letters in applied microbiology.

[37]  F. Hasan,et al.  Biosynthesis and characterization of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) from Bacillus cereus FA11 isolated from TNT-contaminated soil , 2011, Annals of Microbiology.

[38]  V. Bhardwaj,et al.  Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[39]  Janice Gabriel,et al.  The Biology of Cancer , 2005 .

[40]  S. Linder,et al.  Induction of endoplasmic reticulum stress by ellipticine plant alkaloids. , 2004, Molecular cancer therapeutics.